Cooper Companies Inc (COO) To Go Ex-Dividend on July 22nd
Cooper Companies Inc (NYSE:COO) announced a Semi-Annual dividend on Wednesday, July 10th, NASDAQ reports. Stockholders of record on Tuesday, July 23rd will be paid a dividend of 0.03 per share by the medical device company on Wednesday, August 7th. The ex-dividend date of this dividend is Monday, July 22nd.
Cooper Companies has a payout ratio of 0.5% meaning its dividend is sufficiently covered by earnings. Analysts expect Cooper Companies to earn $13.30 per share next year, which means the company should continue to be able to cover its $0.06 annual dividend with an expected future payout ratio of 0.5%.
Shares of COO stock opened at $331.52 on Friday. The company has a market cap of $16.43 billion, a price-to-earnings ratio of 28.39, a P/E/G ratio of 2.52 and a beta of 0.84. Cooper Companies has a fifty-two week low of $228.65 and a fifty-two week high of $343.33. The stock has a 50 day simple moving average of $326.05. The company has a current ratio of 1.21, a quick ratio of 0.68 and a debt-to-equity ratio of 0.42.
Several research firms recently weighed in on COO. Raymond James restated a “buy” rating and set a $26.00 price target on shares of Propetro in a research report on Tuesday, July 2nd. Wells Fargo & Co restated a “buy” rating on shares of Allergan in a research report on Monday, June 10th. Zacks Investment Research lowered Home Bancshares from a “hold” rating to a “sell” rating in a research report on Friday, June 7th. Finally, Northcoast Research restated a “buy” rating and set a $340.00 price target (up from $331.00) on shares of Cooper Companies in a research report on Monday, June 3rd. One research analyst has rated the stock with a sell rating, one has issued a hold rating and eleven have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $318.91.
In other Cooper Companies news, COO Daniel G. Mcbride sold 11,981 shares of the business’s stock in a transaction on Thursday, June 6th. The stock was sold at an average price of $315.99, for a total value of $3,785,876.19. Following the sale, the chief operating officer now directly owns 42,668 shares of the company’s stock, valued at $13,482,661.32. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Jody S. Lindell sold 3,000 shares of the business’s stock in a transaction on Monday, June 24th. The stock was sold at an average price of $328.29, for a total value of $984,870.00. The disclosure for this sale can be found here. Insiders sold 77,678 shares of company stock worth $25,063,536 over the last three months. Corporate insiders own 1.70% of the company’s stock.
About Cooper Companies
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.